Lexology August 1, 2023
Dickinson Wright

The Federal False Claims Act (“FCA”) allows private parties to bring lawsuits in the name of the federal government against defendants who allegedly “knowingly” present a false claim to the government for payment. The question for courts has been what standard should be applied to evaluate a defendant’s “knowledge.” The US Supreme Court recently clarified that courts must examine a defendant’s subjective belief as of the time a claim is submitted.

Medicare and Medicaid offer prescription drug coverage to beneficiaries with payments that are typically capped at a pharmacy’s “usual and customary” rates. In a unanimous June decision, the Supreme Court reversed the Seventh Circuit and found the defendant pharmacies could have violated the FCA by submitting claims for reimbursement...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Pharma, Pharma / Biotech, Provider, Regulations
MedCity FemFwd: What the Future Holds for Women’s Health in 2025
Gastroenterology Year in Review: 2024
How Social Determinants of Health Are Linked to Outcomes in Multiple Myeloma
Understanding alpha-1 antitrypsin deficiency: What you need to know [PODCAST]
What Is Norovirus And What Are Its Symptoms?

Share This Article